Pages that link to "Q34541231"

The following pages link to MEASLES IMMUNIZATION WITH KILLED VIRUS VACCINE. SERUM ANTIBODY TITERS AND EXPERIENCE WITH EXPOSURE TO MEASLES EPIDEMIC. (Q34541231):

Displaying 47 items.

• The role of research in viral disease eradication and elimination programs: lessons for malaria eradication (Q26700366) (← links)
• Status of arenavirus vaccines and their application (Q27485966) (← links)
• Comparison of the immune responses induced by chimeric alphavirus-vectored and formalin-inactivated alum-precipitated measles vaccines in mice (Q28752489) (← links)
• Intranasal administration of a live non-pathogenic avian H5N1 influenza virus from a virus library confers protective immunity against H5N1 highly pathogenic avian influenza virus infection in mice: comparison of formulations and administration rout (Q30873309) (← links)
• Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand (Q31032937) (← links)
• A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles (Q33769306) (← links)
• Delayed diagnosis in atypical measles syndrome (Q34299757) (← links)
• The immunogenicity of heat-inactivated vaccinia virus in rabbits (Q36252287) (← links)
• Emerging diseases: measles (Q36312960) (← links)
• Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection (Q36343347) (← links)
• Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques (Q36539048) (← links)
• Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge (Q36784384) (← links)
• Study of delayed hypersensitivity to myxoviruses induced by vaccines (Q37183623) (← links)
• Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine (Q37208256) (← links)
• Immunisation policies--successes, failures and the future (Q37219942) (← links)
• Morbillivirus vaccines: recent successes and future hopes (Q38202354) (← links)
• Immunisation safety: a priority of the World Health Organization's Department of Vaccines and Biologicals (Q38469610) (← links)
• The control of viral diseases. Problems and prospects viewed in perspective (Q39974461) (← links)
• Application of Immunological Principles to Immunization Practices (Q40027933) (← links)
• Atypical Measles Rash Mimicking Rocky Mountain Spotted Fever (Q40908505) (← links)
• Immunization safety priority project at the World Health Organization (Q43365112) (← links)
• Measles Vaccines Present Status (Q44190250) (← links)
• Reactions to Live-Measles-Virus Vaccine in Children Previously Inoculated with Killed-Virus Vaccine (Q45808336) (← links)
• Altered reactivity to measles virus. Skin test reactivity and antibody response to measles virus antigens in recipients of killed measles virus vaccine (Q45809878) (← links)
• Killed-measles-virus vaccine (Q45826017) (← links)
• Measles Vaccine (Q46300761) (← links)
• Detection of sensitizing tissue culture components in viral vaccines (Q47692205) (← links)
• Measles vaccination before the measles-mumps-rubella vaccine. (Q51872326) (← links)
• Recognition of microbial viability via TLR8 drives TFH cell differentiation and vaccine responses. (Q52725593) (← links)
• Revaccination of previous recipients of killed measles vaccine: clinical and immunologic studies (Q53770637) (← links)
• Sensitization of guinea-pigs to measles vaccines (Q54066335) (← links)
• Successful Vaccines (Q56355933) (← links)
• Inflammatory Disease of the Human Lung of Definite or Presumed Viral Origin. Cytologic and Histologic Topics (Q64381104) (← links)
• Atypical measles syndrome: a continuing problem (Q67466540) (← links)
• Delayed dermal hypersensitivity following killed measles vaccine. Experience in 9-month-old infants (Q69996638) (← links)
• Present status of measles and rubella immunization in the United States: a medical progress report (Q71746828) (← links)
• Pneumonia in atypical measles (Q71829802) (← links)
• Immunosuppressive therapy (Q71900780) (← links)
• Some characteristics of immunity following natural measles and various forms of immunization (Q71931370) (← links)
• Measles and panencephalitis (Q72051837) (← links)
• Reactions to live measles vaccine in children previously given killed measles vaccine (Q72371881) (← links)
• Vaccine-induced hypersensitivity: reactions to live measles and mumps vaccine in prior recipients of inactivated measles vaccine (Q72496859) (← links)
• Severe local reactions to live measles virus vaccine following an immunization program (Q72789203) (← links)
• Measles Vaccination VI. Serological and Clinical Follow-up Analysis 18 Months after a Booster Injection (Q72924453) (← links)
• Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody (Q77890115) (← links)
• Why are vaccines against many human viral diseases still unavailable; an historic perspective? (Q90014164) (← links)
• Chapter 8 Paramyxoviruses (Q93238841) (← links)